This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Specialty societies such as the American College of Radiology are asking lawmakers to reform the federal payment program to end years of negative updates.
A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. The study findings are hopeful for patients with the condition, presenter Kenneth Merrell, MD, of the Mayo Clinic Alix School of Medicine in Rochester, MN, said in an ASTRO statement.
Spiritual beliefs and a distrust of clinical research may partly explain why Black patients choose not to participate in cancer trials, according to research presented September 30 at the American Society for Radiation Oncology (ASTRO) annual meeting. In a recent survey of patients in Baltimore, MD, Black people were more than five times as likely to agree with statements that death or illnesses were determined by God’s will and that God, not research, determined wellness, reported Charlyn Gomez
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
It’s been two and a half years since Microsoft completed its acquisition of Nuance Communications for a reported $19.7 billion. At the time of the March 2022 transaction, Microsoft said it liked Nuance for its core strengths—AI-powered voice recognition and related software and services—across numerous industries.
Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer, according to a study presented September 30 at the American Society for Radiation Oncology (ASTRO) annual meeting. The finding is from a phase III trial that compared the two treatments in 450 patients and could help patients make decisions about their treatment, noted presenter Jason Efstathiou, MD, PhD, of Massachusetts General Hospital.
Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer, according to a study presented September 30 at the American Society for Radiation Oncology (ASTRO) annual meeting. The finding is from a phase III trial that compared the two treatments in 450 patients and could help patients make decisions about their treatment, noted presenter Jason Efstathiou, MD, PhD, of Massachusetts General Hospital.
The RSNA plans to establish its next Global Learning Center in Peru at the Instituto Nacional de Salud del Niño de San Borja in Lima. The center will be supported by a grant from the U.S. Department of Energy's National Nuclear Security Administration (NNSA) and will be part of the RSNA's "Global Health Initiative: Access to Radiology," program, which is intended to improve patient care in low- to middle-resourced countries and to promote peaceful uses of nuclear energy, the society said.
Patients with brain metastases who experience cognitive side effects after radiation therapy appear to eventually regain cognitive function, according to a presentation delivered September 29 at the American Society for Radiation Oncology (ASTRO) meeting in Washington, DC. This recovery was more likely for people treated with targeted radiation techniques rather than standard whole-brain treatment, wrote a team led by Hua-Ren Ryan Cherng, MD, of the University of Maryland Medical Center in Balti
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Currently, there is no standardized reporting requirement related to BACs, and ACR classifies reporting vascular calcifications on breast imaging as optional.
Editor's note: As part of the celebration of AuntMinnie.com's upcoming 25th anniversary, we're presenting 25 for 25 -- a series featuring our most popular content for each of the last 25 years. New articles will be published each Monday until our official anniversary at RSNA 2024. Our top article in 2015 reported on the momentous CMS decision on CT lung cancer screening reimbursement.
A new hand-held scanner developed by UCL researchers can generate highly detailed 3D photoacoustic images in just seconds, paving the way for their use in a clinical setting for the first time and offering the potential for earlier disease diagnosis.
A daily MR imaging technique can quantify tumor changes in glioblastoma patients undergoing MRI-guided radiation therapy, according to a study published September 30 in the International Journal of Radiation Oncology-Biology-Physics. The technique -- called MRI-linear accelerator, or MRI-linac -- can serve as an "early warning system" and help clinicians monitor tumor growth during treatment sooner than standard imaging allows, wrote a team led by first author Kaylie Cullison, PhD, and senior au
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
A reader asked if anyone had successfully started a new radiology private practice recently, particularly one that involved financing, opening up new imaging centers, and fresh payor contracts. There is a vacuum in some areas, especially with the PE-exacerbated instability, and therefore a clear opportunity to those who can muster the manpower (no easy feat).
Siemens Healthineer's Mammomat B.brilliant system. Siemens Healthineers Siemens Healthineers has secured premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for a tomosynthesis version of its Mammomat B.brilliant mammography system. The approval covers new 3D image acquisition and image reconstruction technology called PlatinumTomo, which allows for a 50° acquisition in less than five seconds, according to Siemens, and technology called UltraHD which reduces metal artifacts
Hologic has launched an educational campaign for Breast Cancer Awareness Month called #BustTheMyth. The initiative addresses common misconceptions about the disease and about screening, including the following: Myth: I don’t have a family history of breast cancer, so I don’t need to worry. Response: While genetics can be a factor, 85% of women diagnosed with breast cancer have no family history.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
An ultrasound test that detected 96% of ovarian cancers in postmenopausal women should replace the current standard of care test in the UK according to a new study.
A new hand-held scanner can generate highly detailed 3D photoacoustic images in just seconds, paving the way for their use in a clinical setting for the first time and offering the potential for earlier disease diagnosis.
When physicians want to know more about a patient's risk of cardiovascular disease, they can order a cardiac stress test. But when it comes to risk of stroke, there is no equivalent scalable and cost-effective test of the brain's function to help physicians counsel patients on their potential risk. A questionnaire that asks patients about contributing risk factors is currently the best tool for estimating such risk.
Medical imaging using magnetic resonance imaging (MRI) is very time-consuming since an image has to be compiled from data from many individual measurements. Thanks to the use of machine learning, imaging is also possible with less MRI measurement data, which saves time and costs. However, the prerequisite for this is perfect images that can be used to train the AI models.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Researchers have created a composite hydrogel that enables sustained and consistent drug release, triggered by ultrasound. This breakthrough could transform.
Noting a rapidly changing paradigm for the treatment of rectal cancers, the authors of a new literature review discuss current and emerging principles in MRI assessment and staging.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content